Total Payments
$14,815
2024 Payments
$1,555
Companies
29
Transactions
559
Medicare Patients
746
Medicare Billing
$59,478
Payment Breakdown by Category
Food & Beverage$10,145 (68.5%)
Other$4,550 (30.7%)
Travel$72.85 (0.5%)
Education$47.31 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,145 | 551 | 68.5% |
| Honoraria | $2,700 | 1 | 18.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,850 | 1 | 12.5% |
| Travel and Lodging | $72.85 | 2 | 0.5% |
| Education | $47.31 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $3,362 | 36 | $0 (2023) |
| PFIZER INC. | $2,796 | 48 | $0 (2024) |
| ABBVIE INC. | $1,833 | 85 | $0 (2024) |
| Amgen Inc. | $1,323 | 74 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,208 | 56 | $0 (2024) |
| Janssen Biotech, Inc. | $754.90 | 55 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $726.64 | 45 | $0 (2024) |
| GlaxoSmithKline, LLC. | $479.18 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $375.01 | 17 | $0 (2024) |
| Lilly USA, LLC | $360.86 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,555 | 70 | ABBVIE INC. ($425.21) |
| 2023 | $1,274 | 60 | ABBVIE INC. ($232.64) |
| 2022 | $2,710 | 44 | PFIZER INC. ($1,893) |
| 2021 | $1,094 | 59 | AbbVie Inc. ($289.51) |
| 2020 | $844.44 | 48 | Amgen Inc. ($365.70) |
| 2019 | $4,211 | 83 | Horizon Therapeutics plc ($2,919) |
| 2018 | $1,778 | 101 | Novartis Pharmaceuticals Corporation ($424.37) |
| 2017 | $1,349 | 94 | Janssen Biotech, Inc. ($202.71) |
All Payment Transactions
559 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.63 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $31.52 | General |
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: Rare Disease | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Immunology | ||||||
| 10/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Immunology | ||||||
| 08/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $27.21 | General |
| Category: Immunology | ||||||
| 08/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 169 | 446 | $39,388 | $12,654 |
| 2022 | 7 | 164 | 314 | $33,968 | $12,682 |
| 2021 | 6 | 185 | 342 | $40,198 | $15,429 |
| 2020 | 6 | 228 | 436 | $55,770 | $18,713 |
Total Patients
746
Total Services
1,538
Medicare Billing
$59,478
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 75 | $20,700 | $6,829 | 33.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 38 | 49 | $4,704 | $3,382 | 71.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 30 | $5,520 | $1,804 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 24 | $1,440 | $256.52 | 17.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 244 | $6,832 | $194.93 | 2.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 24 | $192.00 | $188.16 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 63 | $17,388 | $6,150 | 35.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 47 | 68 | $6,528 | $4,344 | 66.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 27 | $4,968 | $1,525 | 30.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 12 | $780.00 | $388.70 | 49.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 16 | $960.00 | $156.46 | 16.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 116 | $3,248 | $85.37 | 2.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 12 | $96.00 | $32.58 | 33.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 81 | $22,356 | $7,483 | 33.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 46 | 74 | $7,104 | $4,734 | 66.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 33 | $6,072 | $2,058 | 33.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 19 | 22 | $1,430 | $970.60 | 67.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 14 | 109 | $3,052 | $113.92 | 3.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 14 | 23 | $184.00 | $69.00 | 37.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 76 | 99 | $26,334 | $7,384 | 28.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 60 | 87 | $8,352 | $6,033 | 72.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 52 | 69 | $11,064 | $3,321 | 30.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 13 | $4,724 | $1,093 | 23.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 16 | $1,040 | $710.80 | 68.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 15 | 152 | $4,256 | $169.90 | 4.0% |
About Dr. Max Harris, MD
Dr. Max Harris, MD is a Rheumatology healthcare provider based in Oak Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053349886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Max Harris, MD has received a total of $14,815 in payments from pharmaceutical and medical device companies, with $1,555 received in 2024. These payments were reported across 559 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($10,145).
As a Medicare-enrolled provider, Harris has provided services to 746 Medicare beneficiaries, totaling 1,538 services with total Medicare billing of $59,478. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Oak Park, IL
- Active Since 06/29/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1053349886
Products in Payments
- KRYSTEXXA (Biological) $3,445
- COSENTYX (Biological) $1,089
- Enbrel (Biological) $985.74
- XELJANZ (Drug) $921.62
- RINVOQ (Biological) $860.05
- ORENCIA (Biological) $726.64
- Humira (Biological) $498.16
- BENLYSTA (Biological) $460.29
- SIMPONI ARIA (Biological) $307.19
- SKYRIZI (Biological) $288.13
- TREMFYA (Drug) $287.46
- Cimzia (Drug) $208.57
- TRULICITY (Drug) $175.71
- Otrexup (Drug) $153.02
- KRYSTEXXA (Drug) $139.21
- OFEV (Drug) $125.26
- STELARA (Biological) $121.93
- Actemra (Biological) $114.46
- SAPHNELO (Biological) $110.74
- ENTRESTO (Drug) $93.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.